World Journal of Gastrointestinal Oncology

Papers
(The median citation count of World Journal of Gastrointestinal Oncology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)
ArticleCitations
Curcumin for gastric cancer: Mechanism prediction via network pharmacology, docking, and in vitro experiments67
MicroRNA-363-3p inhibits colorectal cancer progression by targeting interferon-induced transmembrane protein 155
Nomogram for predicting the prognosis of tumor patients with sepsis after gastrointestinal surgery41
Novel miR-490-3p/hnRNPA1-b/PKM2 axis mediates the Warburg effect and proliferation of colon cancer cells via the PI3K/AKT pathway37
Comment on “Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression”37
Canopy FGF signaling regulator 3 affects prognosis, immune infiltration, and PI3K/AKT pathway in colon adenocarcinoma36
Significance of monitoring imatinib plasma concentration in second-line treatment decisions for c-kit 11 gene-mutated gastrointestinal stromal tumors36
Local excision for middle-low rectal cancer after neoadjuvant chemoradiation: A retrospective study from a single tertiary center34
Traditional Chinese medicine and modern technology: Network pharmacology and omics sequencing in gastric cancer33
Fibrolamellar hepatocellular carcinoma: A rare but unpleasant event31
Chicken skin mucosa surrounding small colorectal cancer could be an endoscopic predictive marker of submucosal invasion30
Usefulness of shear-wave elastography for detection of lymph node metastasis in esophageal and gastric cancer29
Lipid levels and insulin resistance markers in patients with colorectal cancer: Propensity score matching analysis28
Current trends and hotspots of depressive disorders with colorectal cancer: A bibliometric and visual study28
Combining systemic inflammatory response index and albumin fibrinogen ratio to predict early serious complications and prognosis after resectable gastric cancer27
Role of three-dimensional printing and artificial intelligence in the management of hepatocellular carcinoma: Challenges and opportunities27
Artificial intelligence as a predictive tool for gastric cancer: Bridging innovation, clinical translation, and ethical considerations26
Circular RNA hsa_circRNA_101996 modulates gastric cancer cell proliferation and apoptosis through the miR-577/HMGN5 axis26
Controversies around the treatment of peritoneal metastases of colorectal cancer25
KAI1/CD82gene and autotaxin-lysophosphatidic acid axis in gastrointestinal cancers25
Features of synchronous and metachronous dual primary gastric and colorectal cancer25
Diverse roles of FOXO family members in gastric cancer25
Nutrition deprivation affects the cytotoxic effect of CD8 T cells in hepatocellular carcinoma25
Evaluation of short-term effects of drug-loaded microspheres and traditional transcatheter arterial chemoembolization in the treatment of advanced liver cancer25
Impact of SLC16A8 on tumor microenvironment and angiogenesis in colorectal cancer: New therapeutic target insights24
Development and validation of a nomogram for predicting metachronous peritoneal metastasis in colorectal cancer: A retrospective study24
Prognostic relevance of ventricular arrhythmias in surgical patients with gastrointestinal tumors23
Caregiver-involved nutritional support and mindfulness training for patients with gastrointestinal cancer: Effects on malnutrition risk and mood23
Response to osimertinib in a colorectal cancer patient with an EGFR T790M mutation: A case report22
Interleukin-34 promotes the proliferation and epithelial-mesenchymal transition of gastric cancer cells22
Maximizing therapeutic outcomes in hepatocellular carcinoma: Insights into combinatorial strategies21
Clinical benefits of transarterial chemoembolization combined with tyrosine kinase and immune checkpoint inhibitors for unresectable hepatocellular carcinoma21
Clinical analysis of multiple primary gastrointestinal malignant tumors: A 10-year case review of a single-center21
Pretreatment serum albumin-to-alkaline phosphatase ratio is an independent prognosticator of survival in patients with metastatic gastric cancer21
Combining prognostic value of serum carbohydrate antigen 19-9 and tumor size reduction ratio in pancreatic ductal adenocarcinoma20
Efficacy and safety of perioperative therapy for locally resectable gastric cancer: A network meta-analysis of randomized clinical trials19
Impact of Alcian blue and periodic acid Schiff expression on the prognosis of gastric signet ring cell carcinoma19
KIFC3 promotes proliferation, migration and invasion of esophageal squamous cell carcinoma cells by activating EMT and β-catenin signaling19
Vitamin E in the management of pancreatic cancer: A scoping review19
Hsa_circ_0001658 accelerates the progression of colorectal cancer through miR-590-5p/METTL3 regulatory axis19
Efficacy of sorafenib combined with transarterial chemoembolization in the treatment of advanced hepatocellular carcinoma: A meta-analysis18
Roles of the tumor microenvironment in the resistance to programmed cell death protein 1 inhibitors in patients with gastric cancer18
Enhancing the radiosensitivity of colorectal cancer cells by reducing spermine synthase through promoting autophagy and DNA damage18
Impact of baseline steroids on the efficacy of neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma18
Anticipation for hepatic arterial infusion chemotherapy in the treatment of hepatocellular carcinoma17
Identification and validation of extracellular matrix-related genes in the progression of gastric cancer with intestinal metaplasia16
Hepatitis B core-related antigen as a predictive biomarker for recurrence in primary hepatocellular carcinoma: A meta-analysis16
Prognostic value of preoperative fibrinogen, neutrophil-to-lymphocyte ratio, serum alpha-fetoprotein, and prealbumin for patients with primary liver cancer undergoing transarterial chemoembolization16
Potential of damage associated molecular patterns in synergising radiation and the immune response in oesophageal cancer16
Lateral pelvic lymph nodes for rectal cancer: A review of diagnosis and management16
Targeted gene sequencing and bioinformatics analysis of patients with gallbladder neuroendocrine carcinoma: A case report16
Up-regulated programmed cell death protein-1/its ligand 1 expression promotes metabolic dysfunction-associated steatotic liver disease malignant progression16
Comparative study between Embosphere® and Marine gel® as embolic agents for chemoembolization of hepatocellular carcinoma16
Application of Fusobacterium nucleatum as a biomarker in gastrointestinal malignancies16
Impact of baseline hepatitis B virus viral load on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy16
Predictive value of a serum tumor biomarkers scoring system for clinical stage II/III rectal cancer with neoadjuvant chemoradiotherapy15
Visualization analysis of research hotspots and trends on gastrointestinal tumor organoids15
Mixed neuroendocrine and adenocarcinoma of gastrointestinal tract: A complex diagnosis and therapeutic challenge15
Direct interaction between Rab5a and Rab4a enhanced epidermal growth factor-stimulated proliferation of gastric cancer cells15
Prohibitin 1 inhibits cell proliferation and induces apoptosis via the p53-mediated mitochondrial pathway in vitro15
Therapeutic strategies targeting the epidermal growth factor receptor signaling pathway in metastatic colorectal cancer15
Predictive model for non-malignant portal vein thrombosis associated with cirrhosis based on inflammatory biomarkers14
Is sarcopenia effective on survival in patients with metastatic gastric cancer?14
Evaluation of the value of combined detection of tumor markers CA724, carcinoembryonic antigen, CA242, and CA19-9 in gastric cancer14
Efficacy of image-enhanced endoscopy for colorectal adenoma detection: A multicenter, randomized trial14
Correlation between immune-related adverse events and long-term outcomes in pembrolizumab-treated patients with unresectable hepatocellular carcinoma: A retrospective study14
To scope or not - the challenges of managing patients with positive fecal occult blood test after recent colonoscopy14
Diagnostic value of four serum exosome microRNAs panel for the detection of colorectal cancer14
Dopamine and cyclic adenosine monophosphate-regulated phosphoprotein with an apparent Mr of 32000 promotes colorectal cancer growth13
Clinical features of intracerebral hemorrhage in patients with colorectal cancer and its underlying pathogenesis13
Anti-silencing function 1B knockdown suppresses the malignant phenotype of colorectal cancer by inactivating the phosphatidylinositol 3-kinase/AKT pathway13
Precision treatment for human epidermal growth factor receptor 2-amplified advanced rectal cancer: A case report13
BIBR1532 inhibits proliferation and metastasis of esophageal squamous cancer cells by inducing telomere dysregulation13
Study on sex differences and potential clinical value of three-dimensional computerized tomography pelvimetry in rectal cancer patients13
Clinicopathological and radiological characteristics and prediction of survival in colon cancer13
Diffuse reduction of spleen density is a novel prognostic marker for intrahepatic cholangiocarcinoma after curative resection13
Efficacy and safety of radiotherapy in patients with microsatellite stable or proficient mismatch repair colorectal cancer liver metastasis13
Regorafenib combined with programmed cell death-1 inhibitor against refractory colorectal cancer and the platelet-to-lymphocyte ratio’s prediction on effectiveness12
Comprehensive analysis of the role of ubiquitin-specific peptidases in colorectal cancer: A systematic review12
Human β-defensin-1 activates autophagy in human colon cancer cells via regulation of long non-coding RNA TCONS_0001450612
Response of cholangiocarcinoma with epigastric metastasis to lenvatinib plus sintilimab: A case report and review of literature12
RNA-binding protein CPSF6 regulates IBSP to affect pyroptosis in gastric cancer12
Serum biomarkers for the differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma12
Conditional survival probability of distant-metastatic hepatocellular carcinoma: A population-based study12
NOX4 promotes tumor progression through the MAPK-MEK1/2-ERK1/2 axis in colorectal cancer12
Role of molecular biology in the management of pancreatic cancer12
Early results of the integrative epigenomic-transcriptomic landscape of colorectal adenoma and cancer11
Advances in postoperative adjuvant therapy for primary liver cancer11
Helicobacter pylori-related serum indicators: Cutting-edge advances to enhance the efficacy of gastric cancer screening11
Risk factors for the prognosis of colon cancer11
Silent advanced large cell neuroendocrine carcinoma with synchronous adenocarcinoma of the colon: A case report11
Jejunal sarcomatoid carcinoma: A case report and review of literature11
Signet ring cell carcinoma of the appendix and terminal ileum: A case report11
Emerging role of liquid biopsy in rat sarcoma virus mutated metastatic colorectal cancer: A case report11
Exploring the potential function of high expression of ANAPC1 in regulating ubiquitination in hepatocellular carcinoma10
Impact of fibrinogen-to-albumin ratio on the long-term prognosis of patients with advanced HER2-negative gastric cancer receiving immunochemotherapy10
Biological factors driving colorectal cancer metastasis10
Effect of perioperative chemotherapy on resection of isolated pulmonary metastases from colorectal cancer: A single center experience10
Pathologically successful conversion hepatectomy for advanced giant hepatocellular carcinoma after multidisciplinary therapy: A case report and review of literature10
Clinical characteristics of patients with early gastric prematurity cancer and analysis of complications by endoscopic resection10
C-reactive protein to albumin ratio predict responses to programmed cell death-1 inhibitors in hepatocellular carcinoma patients10
Evaluation of efficacy and safety of targeted therapy and immune checkpoint inhibitors in metastatic colorectal cancer10
Computed tomography-based radiomic model for the prediction of neoadjuvant immunochemotherapy response in patients with advanced gastric cancer10
Neoadjuvant chemotherapy without radiation as a potential alternative treatment for locally advanced rectal cancer: A meta-analysis10
Research progress of ginger in the treatment of gastrointestinal tumors10
Laparoscopic liver resection for colorectal liver metastases — short- and long-term outcomes: A systematic review10
Tetramethylpyrazine induces reactive oxygen species-based mitochondria-mediated apoptosis in colon cancer cells10
Bi-specific T1 positive-contrast-enhanced magnetic resonance imaging molecular probe for hepatocellular carcinoma in an orthotopic mouse model10
Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures10
Role of autophagy in cholangiocarcinoma: An autophagy-based treatment strategy10
Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy10
Real-world 10-year retrospective study of the guidelines for diagnosis and treatment of primary liver cancer in China10
Induction chemotherapy with albumin-bound paclitaxel plus lobaplatin followed by concurrent radiochemotherapy for locally advanced esophageal cancer9
Vasoactive intestinal peptide secreting tumour: An overview9
Epidemiological trends of cholangiocarcinoma and gallbladder cancer in Northeastern Italy: Administrative analysis over a 17-year period (2007-2023)9
To explore the mechanism of Yigong San anti-gastric cancer and immune regulation9
N-glycan biosignatures as a potential diagnostic biomarker for early-stage pancreatic cancer9
Advances in endoscopic diagnosis and management of colorectal cancer9
Lnc524369 promotes hepatocellular carcinoma progression and predicts poor survival by activating YWHAZ-RAF1 signaling9
Comprehensive bioinformatic analysis of mind bomb 1 gene in stomach adenocarcinoma9
MEX3A promotes cell proliferation by regulating the RORA/β-catenin pathway in hepatocellular carcinoma9
Mixed neuroendocrine non-neuroendocrine neoplasms in gastroenteropancreatic tract9
Current status of first-line therapy, anti-angiogenic therapy and its combinations of other agents for unresectable hepatocellular carcinoma9
Potential of six-transmembrane epithelial antigen of the prostate 4 as a prognostic marker for colorectal cancer9
Circ_0004592: An auxiliary diagnostic biomarker for gastric cancer9
Risk factors for hepatocellular carcinoma associated with hepatitis C genotype 3 infection: A systematic review9
Systemic treatment for advanced pancreatic cancer9
Dual primary gastric and colorectal cancer: The known hereditary causes and underlying mechanisms9
Exosome technology: A novel and effective drug delivery system in the field of cancer therapy9
Imaging findings of primary monomorphic epitheliotropic intestinal T-cell lymphoma: A case report9
Potential role of coagulation markers in early detection of bone metastasis in gastric cancer: A critical review9
Chlorogenic acid induces hepatocellular carcinoma cell ferroptosis via PTGS2/AKR1C3/GPX4 axis-mediated reprogramming of arachidonic acid metabolism9
Analysis of vascular thrombus and clinicopathological factors in prognosis of gastric cancer: A retrospective cohort study9
Establishment of a cholangiocarcinoma risk evaluation model based on mucin expression levels9
Mechanism of pachymic acid in the treatment of gastric cancer based on network pharmacology and experimental verification9
Metastatic pancreatic and lung cancer patient in complete remission following immunotherapy: A case report and review of literature8
Recent update on comprehensive therapy for advanced hepatocellular carcinoma8
F-box and leucine-rich repeat 6 promotes gastric cancer progression via the promotion of epithelial-mesenchymal transition8
Effect of hepatic artery resection and reconstruction on the prognosis of patients with advanced hilar cholangiocarcinoma8
Evaluation of three lymph node staging systems for prognostic prediction in gastric cancer: A systematic review and meta-analysis8
Characteristics and therapeutic strategies for familial gastrointestinal stromal tumors8
Current and future research directions in cellular metabolism of colorectal cancer: A bibliometric analysis8
Clinical efficacy and pathological outcomes of transanal endoscopic intersphincteric resection for low rectal cancer8
Overgrowth of Lactobacillus in gastric cancer8
Blood-based machine learning classifiers for early diagnosis of gastric cancer via multiple miRNAs8
Comparison of ethanol-soaked gelatin sponge and microspheres for hepatic arterioportal fistulas embolization in hepatic cellular carcinoma8
Gastric schwannoma: Computed tomography and perigastric lymph node characteristics8
Combination therapy strategy based on selective internal radiation therapy as conversion therapy for inoperable giant hepatocellular carcinoma: A case report8
Shi-pi-xiao-ji formula suppresses hepatocellular carcinoma by reducing cellular stiffness through upregulation of acetyl-coA acetyltransferase 18
Identification of patients with advanced pancreatic cancer who might benefit from third-line chemotherapy8
Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons8
Importance of early detection in multiple endocrine neoplasia type 1: Clinical insights and future directions8
Potential role of long noncoding RNA RP5-881L22.5 as a novel biomarker and therapeutic target of colorectal cancer8
Postoperative delirium: A tragedy for elderly cancer patients8
Assessment of new pathological markers in early stage colon cancer: Insights and limitations8
Baitouweng decoction suppresses growth of esophageal carcinoma cells through miR-495-3p/BUB1/STAT3 axis8
Navigating the complex landscape of crawling-type gastric adenocarcinomas: Insights and implications for clinical practice8
Sm-like 5 knockdown inhibits proliferation and promotes apoptosis of colon cancer cells by upregulating p53, CDKN1A and TNFRSF10B7
Cohort study to assess geographical variation in cholangiocarcinoma treatment in England7
Transarterial chemoembolization combined with lenvatinib vs transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A systematic review and meta-analy7
Cryptotanshinone inhibits cytotoxin-associated gene A-associated development of gastric cancer and mucosal erosions7
Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives7
Effect of Nutrition Risk Screening 2002-guided enteral nutrition on nutritional status in gastrointestinal tumor patients7
Improving clinical outcomes of patients with hepatocellular carcinoma: Role of antiviral therapy, conversion therapy, and palliative therapy7
Application of neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in curative surgery for esophageal cancer: A meta-analysis7
Impact of Linggui Zhugan decoction on microwave ablation outcomes and recurrence in liver cancer7
Nomogram-based prognostic stratification for resectable gastric signet-ring cell carcinoma and adenocarcinoma: A retrospective cohort study7
Young-onset colorectal cancer: A review7
Undifferentiated high-grade pleomorphic sarcoma of the common bile duct: A case report and review of literature7
Prognosis value of heat-shock proteins in esophageal and esophagogastric cancer: A systematic review and meta-analysis7
Epidemiology and outcome of individuals with intraductal papillary neoplasms of the bile duct7
Network pharmacology- and molecular docking-based exploration of the molecular mechanism underlying Jianpi Yiwei Recipe treatment of gastric cancer7
Network pharmacology-based analysis of heat clearing and detoxifying drug JC724 on the treatment of colorectal cancer7
Transcription factor glucocorticoid modulatory element-binding protein 1 promotes hepatocellular carcinoma progression by activating Yes-associate protein 17
Hypoxia-inducible factor 1-alpha and lactate dehydrogenase-A axis in metabolic changes and aggression in esophageal squamous-cell carcinoma7
Relationship between gastric mucosal atrophy by endoscopy and non-ampullary duodenal epithelial tumors7
Construction of CDKN2A-related competitive endogenous RNA network and identification of GAS5 as a prognostic indicator for hepatocellular carcinoma7
Molecular regulatory mechanism of ferroptosis and its role in gastrointestinal oncology: Progress and updates7
Progress of traditional Chinese medicine in the prevention and treatment of colorectal cancer7
Small bowel adenocarcinoma: An overview7
Real-world clinical effectiveness of sorafenib among patients with unresectable hepatocellular carcinoma at two centers in the United States7
New frontiers in liver ultrasound: From mono to multi parametricity7
Comprehensive serum proteomics profiles and potential protein biomarkers for the early detection of advanced adenoma and colorectal cancer7
Prognostic significance of serum inflammation indices for different tumor infiltrative pattern types of gastric cancer7
Drug-eluting beads chemoembolization combined with programmed cell death 1 inhibitor and lenvatinib for large hepatocellular carcinoma7
Personalized treatment selection in colorectal cancer with peritoneal metastasis: Do we need statistically validated indicators or cultural shift?6
Oxocrebanine inhibits the proliferation of hepatocellular carcinoma cells by promoting apoptosis and autophagy6
Prognosis in stage II colon cancer: Expanding the horizons of risk factors6
Risk of hepatocellular carcinoma according to body mass index and waist circumference in nonalcoholic fatty liver disease6
Human β-defensin-1 affects the mammalian target of rapamycin pathway and autophagy in colon cancer cells through long non-coding RNA TCONS_000145066
TRIPLET combined with microwave ablation: A novel treatment for advanced hepatocellular carcinoma6
Nitric oxide synthase 1 inhibits the progression of esophageal cancer through interacting with nitric oxide synthase 1 adaptor protein6
Present situation of minimally invasive surgical treatment for early gastric cancer6
Current guidelines in the surgical management of hereditary colorectal cancers6
microRNA-627-5p inhibits colorectal cancer cell proliferation, migration and invasion by targeting Wnt26
Analysis of serum S100A12, soluble advanced glycation end products receptor, and gut microbiome in elderly patients with colorectal cancer6
Diagnostic accuracy of the multi-target stool DNA test in detecting colorectal cancer: A hospital-based study6
Prognostic analysis of related factors of adverse reactions to immunotherapy in advanced gastric cancer and establishment of a nomogram model6
Modified albumin-bilirubin predicted survival of unresectable hepatocellular carcinoma patients treated with immunotherapy6
Advances and global trends of precancerous lesions of gastric cancer: A bibliometric analysis6
Identification of key hub genes associated with anti-gastric cancer effects of lotus plumule based on machine learning algorithms6
Chronic myelogenous leukemia secondary to colon cancer: A case report6
Development and validation of a nomogram for predicting lymph node metastasis in early gastric cancer6
Diabetes mellitus contribution to the remodeling of the tumor microenvironment in gastric cancer6
Emerging role of caldesmon in cancer: A potential biomarker for colorectal cancer and other cancers6
Clinical and socioeconomic determinants of survival in biliary tract adenocarcinomas6
Risk factors, prognostic predictors, and nomograms for pancreatic cancer patients with initially diagnosed synchronous liver metastasis6
Mixed neuroendocrine non-neuroendocrine tumors: The quest for evidence6
Real-world 10-year retrospective study of the guidelines for diagnosis and treatment of primary liver cancer in China6
Expression significance of biomarker MORC4 in colorectal cancer patients and its relationship with pathological features and prognosis6
Development and validation of a machine learning-based early prediction model for massive intraoperative bleeding in patients with primary hepatic malignancies6
Insight on BRAFV600E mutated colorectal cancer immune microenvironment6
Factors associated with false fecal immunochemical test results in colorectal cancer screening6
Role of myosin heavy chain 9 in gastrointestinal tumorigenesis: A comprehensive review6
Neoadjuvant therapy in resectable pancreatic cancer: A promising curative method to improve prognosis6
Should we perform sigmoidoscopy for colorectal cancer screening in people under 45 years?6
Correction to “Novel long non-coding RNA LINC02532 promotes gastric cancer cell proliferation, migration, and invasion in vitro5
Clinical management for malignant afferent loop obstruction5
Effects ofHelicobacter pyloriinfection in gastrointestinal tract malignant diseases: From the oral cavity to rectum5
Risk factors for hepatocellular carcinoma in cirrhosis: A comprehensive analysis from a decade-long study5
Long non-coding RNA CDKN2B-AS1 promotes hepatocellular carcinoma progression via E2F transcription factor 1/G protein subunit alpha Z axis5
Metastasizing to the colon from triple-negative breast cancer: A case report and review of literature5
Advances in targeted therapy for human epidermal growth factor receptor 2 positive in advanced gastric cancer5
Dynamic contrast enhanced ultrasound in differential diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis5
Hypercoagulation after neoadjuvant immunochemotherapy as a new prognostic indicator in patients with locally advanced gastric cancer undergoing surgery5
Multi-slice spiral computed tomography in differential diagnosis of gastric stromal tumors and benign gastric polyps, and gastric stromal tumor risk stratification assessment5
Vascular endothelial growth factor pathway’s influence on bevacizumab efficacy in metastatic colorectal cancer treatment5
Robotic resection of duodenal gastrointestinal stromal tumour: Preliminary experience from a single centre5
Evaluating the causal relationship between human blood metabolites and gastroesophageal reflux disease5
Prediction of pathological complete response and prognosis in locally advanced rectal cancer5
BCAR3 and BCAR3-related competing endogenous RNA expression in hepatocellular carcinoma and their prognostic value5
Analysis of load status and management strategies of main caregivers of patients with malignant tumors of digestive tract5
Drug-eluting bead transarterial chemoembolization as neoadjuvant therapy pre-liver transplantation for advanced-stage hepatocellular carcinoma5
Correction to "MicroRNA-320a suppresses tumor progression by targeting PBX3 in gastric cancer and is downregulated by DNA methylation"5
Accuracy of dual-contrast gastrointestinal ultrasonography in predicting lymph node metastasis in older adults with gastric cancer5
Evaluation of tumor budding, desmoplastic reaction, and lymphocytic infiltration in predicting survival for pancreatic ductal adenocarcinoma5
Preoperatively predicting vessels encapsulating tumor clusters in hepatocellular carcinoma: Machine learning model based on contrast-enhanced computed tomography5
N-myc downstream regulated gene 1 inhibition of tumor progression in Caco2 cells5
Scoping out the future: The application of artificial intelligence to gastrointestinal endoscopy5
Novel tumor marker index combining carcinoembryonic antigen and carbohydrate antigen 19-9: New prognostic factor for metastatic colorectal cancer5
Metastasis-associated lung adenocarcinoma transcript 1 molecular mechanisms in gastric cancer progression5
Combination of neutrophil gelatinase-associated lipocalin and matrix metalloproteinase-9 are biomarkers for the detection of colon tubular adenocarcinoma5
Efficacy of neoadjuvant chemotherapy for initially resectable colorectal liver metastases: A retrospective cohort study5
Challenges in early detection and endoscopic resection of esophageal cancer: There is a long way to go5
Clinical implications and perspectives of portal venous circulating tumor cells in pancreatic cancer4
Artificial intelligence to predict hepatocellular carcinoma risk in cirrhosis4
Small particle drug-eluting beads-transarterial chemoembolization combined with targeted therapy in the clinical treatment of unresectable liver cancer4
Multidisciplinary discussion and management of synchronous colorectal liver metastases: A single center study in China4
Systemic Inflammation Response Index and weight loss as prognostic factors in metastatic pancreatic cancer: A concept study from the PANTHEIA-SEOM trial4
Consolidation chemotherapy with capecitabine after neoadjuvant chemoradiotherapy in high-risk patients with locally advanced rectal cancer: Propensity score study4
0.097105979919434